+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Access Device Market by Type, Age Group, End User, Application - Global Forecast 2026-2032- Product Image
Vascular Access Device Market by Type, Age Group, End User, Application - Global Forecast 2026-2032- Product Image
Sale

Vascular Access Device Market by Type, Age Group, End User, Application - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4985903
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vascular Access Device Market is projected to reach USD 6.61 Billion in 2026. It is expected to continue growing at a CAGR of 7.89%, reaching USD 10.47 Billion by 2032.

The vascular access device market is expanding as hospitals, ambulatory infusion centers, dialysis providers, and oncology clinics standardize safer, longer-duration access for complex therapies. Demand is anchored by central venous catheters, peripherally inserted central catheters, implantable ports, midline catheters, peripheral IV catheters, and dialysis access products used across chemotherapy, parenteral nutrition, antibiotic therapy, critical care, fluid administration, blood sampling, and renal replacement therapy.

Verified clinical priorities continue to shape purchasing: reducing catheter-related bloodstream infections, improving first-attempt insertion success, minimizing thrombosis and occlusion, preventing extravasation, and supporting care migration from inpatient to outpatient and home-based settings. Guidelines from organizations such as the CDC, Infusion Nurses Society, KDOQI, and WHO reinforce sterile insertion, appropriate device selection, surveillance, hand hygiene, and maintenance practices, making evidence-based vascular access device selection a core patient-safety, quality, and cost-control issue.

Transformative Shifts in Vascular Access

The vascular access device landscape is shifting from procedure-volume growth alone to value-based vascular access management. Providers are prioritizing ultrasound-guided insertion, antimicrobial and antithrombogenic surfaces, needleless connectors, closed-system transfer and access components, securement technologies, tip-confirmation systems, and standardized line-care bundles to lower avoidable complications and improve therapy continuity.

Care delivery is also changing. Oncology infusion, long-term antibiotics, home parenteral nutrition, biologic therapy, and dialysis are increasingly managed outside traditional acute-care settings, which raises demand for durable devices, trained vascular access teams, remote documentation, patient education, and products that simplify maintenance for patients and caregivers. Procurement decisions are increasingly tied to clinical evidence, compatibility with infection-prevention protocols, usability, supply reliability, and total cost of care rather than device price alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative enabler across the vascular access device lifecycle. In clinical workflows, AI-assisted imaging and decision-support tools can help identify suitable vessels, flag difficult-access patients, recommend device type based on therapy duration and infusate characteristics, and support surveillance for infection, occlusion, extravasation, malposition, and thrombosis risk.

Beyond bedside care, AI is improving inventory optimization, utilization analytics, adverse-event signal detection, training standardization, and post-market surveillance. Its impact is strongest when integrated with electronic health records, ultrasound systems, infusion documentation, medication administration records, and quality dashboards, while still requiring clinician oversight, validated datasets, cybersecurity controls, bias monitoring, and regulatory-grade transparency.

Key Regional Insights Across Major Markets

Asia-Pacific is an increasingly important region for vascular access devices because of expanding hospital capacity, rising access to cancer treatment, growth in dialysis services, and increasing adoption of PICCs, implantable ports, midline catheters, and ultrasound-guided placement across China, India, Japan, South Korea, Australia, and ASEAN markets. Japan and Australia emphasize quality protocols, clinical governance, and advanced vascular access technologies, while China and India combine large patient populations with accelerating investment in tertiary care, oncology centers, nephrology services, and outpatient infusion models.

North America remains a technology and protocol leader, supported by strong adoption of vascular access teams, CDC-aligned CLABSI prevention bundles, oncology infusion networks, antimicrobial and power-injectable devices, and high utilization of hemodialysis and long-term infusion therapy. Europe benefits from mature hospital systems, strong infection-prevention programs, and EU medical device regulation that heightens expectations for clinical evidence, traceability, and post-market monitoring. Latin America is seeing demand tied to private hospital expansion, oncology access, and renal care modernization, with Brazil and Mexico acting as key anchors. The Middle East is advancing through premium hospital infrastructure, medical tourism, and renal care investment, particularly in Gulf health systems, while Africa shows rising need for essential vascular access products as critical-care, dialysis, and oncology capacity develop, though reimbursement variability, procurement constraints, and access to trained inserters remain important barriers.

Key Group Insights for Strategic Planning

ASEAN markets are gaining relevance as public and private hospital networks expand and governments invest in oncology, nephrology, intensive care, and universal health coverage initiatives. Demand is strengthened by the need for reliable peripheral IV catheters, central venous access, ports, and dialysis access products in urban tertiary hospitals and growing provincial care networks. GCC countries are prioritizing premium hospital infrastructure, diabetes-linked renal care, medical tourism, digital health, and international accreditation standards, supporting demand for safer catheters, implantable ports, dialysis access devices, securement systems, and standardized line maintenance protocols.

The European Union is driven by rigorous clinical governance, medical device regulation, hospital value analysis, and procurement emphasis on safety evidence, post-market performance, and infection-control compliance. BRICS countries offer scale through large chronic-disease burdens, expanding hospital admissions, oncology treatment needs, and renal replacement therapy demand, although affordability, domestic manufacturing, and public procurement policies strongly influence adoption. G7 markets remain innovation-led, with greater use of advanced materials, ultrasound guidance, and vascular access specialty teams, while NATO member health systems increasingly emphasize resilient medical supply chains, standardized procurement, emergency preparedness, and dependable access to critical vascular access consumables.

Key Country Insights in Vascular Access

The United States leads in vascular access device adoption due to advanced infusion therapy, large oncology and dialysis populations, widespread outpatient infusion services, and strong quality measurement around central line-associated bloodstream infection reduction. Canada emphasizes universal care pathways, patient safety, antimicrobial stewardship, and standardized hospital protocols. Mexico and Brazil are expanding private hospital networks, oncology services, and renal care capacity, creating demand for reliable peripheral access, central venous catheters, ports, and hemodialysis access products.

The United Kingdom, Germany, France, Italy, and Spain rely on mature hospital procurement systems, infection-prevention programs, national clinical guidance, and increasing use of specialty vascular access teams to improve insertion success and reduce complications. Russia remains influenced by hospital modernization, renal care requirements, and local supply priorities. China and India represent major volume opportunities, driven by cancer treatment expansion, chronic kidney disease burden, diabetes prevalence, critical-care investment, and rising procedural standardization. Japan and South Korea focus on high-quality devices, aging-population care, oncology infusion, dialysis services, and advanced hospital infrastructure, while Australia combines evidence-based clinical practice with strong outpatient infusion, home care, and renal care demand.

Actionable Recommendations for Industry Leaders

Industry leaders should align product portfolios with clinically validated outcomes, especially infection reduction, catheter dwell time, insertion efficiency, securement performance, thrombosis mitigation, tip-position accuracy, and patient comfort. Evidence packages should include real-world data, compatibility with care bundles, usability testing, training outcomes, and health-economic models that quantify avoided complications, fewer device replacements, reduced procedure time, and workflow savings.

Commercial teams should prioritize vascular access education, ultrasound-guided insertion support, outpatient infusion partnerships, dialysis and oncology channel strategies, and region-specific regulatory readiness. Manufacturers can strengthen resilience by qualifying multiple suppliers, localizing production or packaging where appropriate, improving sterilization and logistics continuity, and embedding digital tools that enhance documentation, training, traceability, adverse-event monitoring, and post-market performance evaluation.

Research Methodology and Data Validation

This executive summary is built from a structured methodology combining secondary research, regulatory review, clinical guideline assessment, product portfolio evaluation, hospital procurement signals, reimbursement environment review, and macro-health indicators such as cancer incidence, chronic kidney disease prevalence, diabetes burden, dialysis utilization, hospital infrastructure, intensive-care capacity, and outpatient infusion adoption.

Insights are triangulated through top-down demand drivers and bottom-up segment analysis across device type, application, end user, technology, material, and geography. Validation emphasizes credible public sources, peer-reviewed clinical evidence, regulatory databases, professional society guidance, infection-prevention standards, public health data, and consistency checks across regional healthcare systems, while excluding unverified estimates, unsupported projections, and speculative sizing assumptions.

Conclusion and Strategic Outlook

The vascular access device market is moving toward safer, smarter, and more patient-centered access management. Demand is supported by oncology, renal care, critical care, antimicrobial technology, ultrasound guidance, home infusion, outpatient therapy, and hospital quality initiatives that prioritize fewer complications and more reliable therapy delivery.

Organizations that combine clinically proven devices with training, digital intelligence, resilient supply chains, and region-specific commercialization will be best positioned to meet healthcare provider needs. In a market where complications carry clinical, operational, and financial consequences, verified outcomes, regulatory compliance, and workflow integration will define durable leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Vascular Access Device Market, by Type
7.1. Central Venous Catheters
7.2. Peripheral Vascular Access Devices
7.2.1. Long Peripheral Intravenous Catheter
7.2.2. Short Peripheral Intravenous Catheter
8. Vascular Access Device Market, by Age Group
8.1. Adult
8.2. Geriatric
8.3. Pediatric
9. Vascular Access Device Market, by End User
9.1. Ambulatory Surgical Centers
9.2. Home Healthcare Settings
9.3. Hospitals & Clinics
10. Vascular Access Device Market, by Application
10.1. Blood Transfusion
10.2. Diagnostics & Testing
10.3. Drug Administration
10.3.1. Antibiotic Infusion
10.3.2. Chemotherapy
11. Asia-Pacific Vascular Access Device Market
12. Europe Vascular Access Device Market
13. North America Vascular Access Device Market
14. Latin America Vascular Access Device Market
15. Africa Vascular Access Device Market
16. Middle East Vascular Access Device Market
17. NATO Vascular Access Device Market
18. G7 Vascular Access Device Market
19. BRICS Vascular Access Device Market
20. European Union Vascular Access Device Market
21. ASEAN Vascular Access Device Market
22. GCC Vascular Access Device Market
23. China Vascular Access Device Market
24. United States Vascular Access Device Market
25. Japan Vascular Access Device Market
26. India Vascular Access Device Market
27. Germany Vascular Access Device Market
28. United Kingdom Vascular Access Device Market
29. Australia Vascular Access Device Market
30. France Vascular Access Device Market
31. South Korea Vascular Access Device Market
32. Italy Vascular Access Device Market
33. Canada Vascular Access Device Market
34. Russia Vascular Access Device Market
35. Brazil Vascular Access Device Market
36. Mexico Vascular Access Device Market
37. Spain Vascular Access Device Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. 3M Company
39.2. Access Vascular, Inc.
39.3. AMECATH
39.4. AngioDynamics, Inc.
39.5. Argon Medical Devices, Inc.
39.6. Asahi Kasei Medical Co., Ltd.
39.7. B. Braun Melsungen AG
39.8. Baxter International Inc.
39.9. Becton, Dickinson and Company
39.10. Cook Medical, Inc.
39.11. Edwards Lifesciences Corporation
39.12. Fresenius Medical Care AG & Co. KGaA
39.13. Fujifilm Sonosite, Inc.
39.14. ICU Medical, Inc.
39.15. Kimal PLC
39.16. Medical Components, Inc.
39.17. Medtronic PLC
39.18. Nipro Medical Corporation
39.19. Prodimed
39.20. Semler Technologies Inc.
39.21. Siemens Healthcare AG
39.22. Teleflex Incorporated
39.23. Terumo Corporation
39.24. Versago Vascular Access
39.25. Vygon SA
39.26. W. L. Gore & Associates, Inc
List of Figures
FIGURE 1. GLOBAL VASCULAR ACCESS DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VASCULAR ACCESS DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VASCULAR ACCESS DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VASCULAR ACCESS DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VASCULAR ACCESS DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL VASCULAR ACCESS DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VASCULAR ACCESS DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VASCULAR ACCESS DEVICE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL LONG PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL LONG PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL LONG PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HOME HEALTHCARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HOME HEALTHCARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HOME HEALTHCARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIAGNOSTICS & TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIAGNOSTICS & TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIAGNOSTICS & TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG ADMINISTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG ADMINISTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG ADMINISTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANTIBIOTIC INFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANTIBIOTIC INFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANTIBIOTIC INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CHEMOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CHEMOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CHEMOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 59. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 60. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 61. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 64. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 66. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 67. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 68. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. EUROPE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 87. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 88. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 89. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 99. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 101. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 102. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 103. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. NATO VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 108. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 109. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 110. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. G7 VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 113. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 115. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 116. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 117. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. BRICS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 129. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 130. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 131. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. ASEAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 134. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 136. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 137. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. GCC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 142. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 143. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 144. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 145. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 148. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 150. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 151. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 152. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 155. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 156. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 157. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 158. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 159. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 162. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 163. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 164. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 165. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 166. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 169. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 171. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 172. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 173. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 178. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 179. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 184. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 185. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 186. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 190. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 192. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 193. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 194. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 197. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 199. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 200. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 201. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 204. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 205. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 206. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 207. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 208. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 213. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 214. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 215. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 219. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 220. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 221. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 222. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 226. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 227. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 228. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 229. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 232. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 234. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 235. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 236. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 241. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2032 (USD MILLION)
TABLE 242. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 243. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Vascular Access Device market report include:
  • 3M Company
  • Access Vascular, Inc.
  • AMECATH
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cook Medical, Inc.
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Fujifilm Sonosite, Inc.
  • ICU Medical, Inc.
  • Kimal PLC
  • Medical Components, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • Prodimed
  • Semler Technologies Inc.
  • Siemens Healthcare AG
  • Teleflex Incorporated
  • Terumo Corporation
  • Versago Vascular Access
  • Vygon SA
  • W. L. Gore & Associates, Inc

Table Information

Report AttributeDetails
No. of Pages196
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.61 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.47 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Vascular Access Device - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Vascular Access Device - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Vascular Access Devices - Global Strategic Business Report - Product Image

Vascular Access Devices - Global Strategic Business Report

  • Report
  • 479 Pages
  • Global
From
Vascular Access Devices Market Report and Forecast 2025-2034 - Product Image

Vascular Access Devices Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Vascular Access Devices Market Report 2026 - Product Image

Vascular Access Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Vascular Access Devices Market - Product Image

Vascular Access Devices Market

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.